7 insiders reported 123 Form 4 transactions for Apogee Therapeutics, Inc. (APGE) over the past 18 months (most recent 2026-08-11). Recent activity: Harwin Peter Evan (Director) Buy 31,838 shares, Fairmount Healthcare Fund II L.P. (Director) Buy 31,838 shares, Fairmount Funds Management LLC (Director) Buy 31,838 shares, Kiselak Tomas (Director) Buy 31,838 shares, Harwin Peter Evan (Director) Buy 10,370 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Harwin Peter Evan | Director | Buy | 31,838 | $541,246 |
| 2026-08-11 | Fairmount Healthcare Fund II L.P. | Director | Buy | 31,838 | $541,246 |
| 2026-08-11 | Fairmount Funds Management LLC | Director | Buy | 31,838 | $541,246 |
| 2026-08-11 | Kiselak Tomas | Director | Buy | 31,838 | $541,246 |
| 2026-08-11 | Harwin Peter Evan | Director | Buy | 10,370 | $454,724 |
| 2026-08-11 | Fairmount Healthcare Fund II L.P. | Director | Buy | 10,370 | $454,724 |
| 2026-08-11 | Fairmount Funds Management LLC | Director | Buy | 10,370 | $454,724 |
| 2026-08-11 | Kiselak Tomas | Director | Buy | 10,370 | $454,724 |
| 2026-08-07 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-08-07 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $737,935 |
| 2026-07-24 | Henderson Jane | Chief Financial Officer | Sell | 15,000 | $0 |
| 2026-07-16 | Dambkowski Carl | Chief Medical Officer | Sell | 8,000 | $0 |
| 2026-07-10 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $2.7M |
| 2026-07-10 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 75,046 | $0 |
| 2026-07-02 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-07-02 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $730,070 |
| 2026-06-24 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 80,000 | $10.6M |
| 2026-06-24 | Dambkowski Carl | Chief Medical Officer | Sell | 26,400 | $3.5M |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 6,770 | $556,562 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 7,654 | $633,598 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 1,080 | $90,914 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 1,577 | $134,345 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 2,305 | $198,852 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 614 | $53,350 |
| 2026-06-05 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
Source: SEC Form 4 filings · as of 2026-08-11